TB-500: The Complete Guide
A thorough, research-grounded look at TB-500 — the systemic healing peptide derived from Thymosin Beta-4, how it works, what the evidence shows, and how it compares to BPC-157.
This guide summarizes published research on TB-500 and Thymosin Beta-4. It is educational only and not a substitute for advice from a qualified healthcare professional. Sources are listed at the end.
TB-500 is one of the two best-known peptides in the healing and recovery world — the frequent partner to BPC-157. Where BPC-157 is often thought of as the "localized" repair peptide, TB-500 is prized for its systemic reach: it's studied for helping repair processes throughout the body rather than just at one spot. It's a favorite among people dealing with soft-tissue injuries, and it has a substantial base of animal research behind it.
This guide covers what TB-500 is (including an important distinction most sources gloss over), how it works, what the research does and doesn't establish, how it compares to BPC-157, and the practical details of its use — with the honest caveats a research compound deserves.
What TB-500 Is
TB-500 is a synthetic peptide based on Thymosin Beta-4 (often written Tβ4), a naturally occurring protein found in nearly every cell in your body. Thymosin Beta-4 is one of the body's own major players in tissue repair — it's released at sites of injury and is deeply involved in the healing process. TB-500 was created to capture the most active healing-related part of that protein in a smaller, synthetic form.
Because Thymosin Beta-4 is naturally present throughout the body and central to how we heal, the interest in a synthetic version is easy to understand: if you could supply more of the active healing component, perhaps you could support the body's repair processes more effectively.
The Fragment vs the Parent Protein (An Important Distinction)
Here's a point of accuracy that most TB-500 discussions skip, and it matters for understanding the evidence honestly. Thymosin Beta-4 is a full protein of 43 amino acids. TB-500 is not the whole protein — it's a short fragment based on the specific region (a sequence known as LKKTETQ) that's most directly responsible for the protein's actin-binding and healing-related activity.
Think of the full Thymosin Beta-4 protein as a long tool with several functions, and TB-500 as a copy of the single most important working end. The fragment keeps the key actin-binding region that drives cell migration and repair, but it doesn't include the rest of the parent molecule.
Why this distinction matters
Much of the strongest human research in this area was actually conducted on the full-length Thymosin Beta-4 protein (for example, in clinical trials for eye-surface and wound healing), not on the shorter TB-500 fragment specifically. The fragment and the full protein share the key active region, so the mechanism is expected to carry over — but it's honest to note that the fragment itself has less direct human trial data than the parent protein. We think you should know that rather than have it blurred together, as it often is.
How TB-500 Works
TB-500's healing mechanism centers on a protein inside your cells called actin. Actin is one of the fundamental building blocks of cells — it forms the internal scaffolding that lets cells hold their shape and, crucially, move. Cell movement is at the heart of healing: to repair an injury, cells have to migrate to the damaged area.
TB-500 binds to a form of actin (called G-actin) and helps regulate how it's organized. By influencing actin dynamics, it supports the ability of repair cells to travel to where they're needed. This single mechanism drives several downstream healing effects:
Cell Migration
By regulating actin, TB-500 supports the movement of repair cells to injury sites — the essential first step in tissue healing.
New Blood Vessel Formation
It's studied for promoting angiogenesis — the growth of new blood vessels that bring oxygen and nutrients to healing tissue.
Reduced Inflammation
Thymosin Beta-4 has documented anti-inflammatory activity, which may help create a better environment for repair.
Less Scar Tissue
Research suggests it may support healing with reduced fibrosis (excess scar tissue), favoring more functional tissue repair.
The "systemic" advantage
One of TB-500's defining features is that it's thought to distribute throughout the body rather than staying where it's injected. In practical terms, this means it doesn't need to be injected right at the site of an injury — an injection anywhere is thought to produce body-wide effects. This is a key difference from how BPC-157 is often used, and it's part of why TB-500 is described as a "systemic" healing peptide.
What TB-500 Is Studied For
Based on the research (primarily animal and cell studies, plus human data on the parent protein), TB-500 is most commonly explored in these areas:
Muscle Injuries
Strains, tears, and general muscle recovery — one of the most common reasons people are interested in it.
Tendon & Ligament Repair
Connective tissue injuries, which are notoriously slow to heal due to limited blood supply.
Wound & Skin Healing
An area with some of the strongest research on the parent Thymosin Beta-4 protein.
Flexibility & Joint Comfort
Users often report improvements in flexibility and joint comfort, likely tied to its tissue-repair effects.
Cardiac Tissue (Research)
Animal studies have explored Thymosin Beta-4's role in heart tissue repair after injury — an active research area.
General Recovery
Broad soft-tissue recovery and post-exertion repair, especially valued for its whole-body reach.
What the Evidence Actually Shows
Being straight about the evidence is important, because it's an area where enthusiasm often runs ahead of the data.
The Strong Part
The animal and laboratory research supporting Thymosin Beta-4 and its active fragment is genuinely substantial. Multiple independent labs have demonstrated healing effects across different injury models — wound healing, soft-tissue repair, cell migration, and more. When independent researchers replicate a finding across many models, that's a real sign of genuine biological activity. The underlying mechanism (actin binding, cell migration, angiogenesis) is also well-characterized and internally consistent.
The Honest Limitation
The direct human trial evidence for the TB-500 fragment specifically is limited. Most of the strongest human data used the full-length Thymosin Beta-4 protein — for instance, in formulations studied for eye-surface (corneal) and wound healing. The fragment shares the key active region, so the mechanism is expected to translate, but rigorous human trials of the fragment itself for muscle and tendon repair are still lacking. As of 2026, this remains an evolving area, including ongoing regulatory review of these peptides.
Our honest position
TB-500 has a strong mechanistic and animal-research foundation, and a long track record of use in the research and athletic communities. But it's a research compound, and the human evidence for the fragment is still developing. We'd rather you understand it as "well-supported in animal research with a sound mechanism, but not yet validated by large human trials" than have it oversold. That's the accurate picture.
TB-500 vs BPC-157
These two are the healing world's most famous pair, and they're frequently discussed (and used) together. Understanding how they differ helps clarify what each brings.
| TB-500 | BPC-157 | |
|---|---|---|
| Derived from | Thymosin Beta-4 protein | A protein in gastric juice |
| Main mechanism | Actin regulation & cell migration | Angiogenesis & nitric-oxide pathways |
| Reach | Systemic (whole-body) | Often used more locally |
| Particular strength | Broad soft-tissue & systemic repair | Gut healing; localized tendon/tissue repair |
| Injection site | Anywhere (systemic distribution) | Often near the injury |
Because they work through different mechanisms, they're often combined — the pairing is popularly known as the "Wolverine Stack." The logic is that hitting healing from two different angles (actin/cell-migration plus angiogenesis) may be more complete than either alone. We carry both individually and as a combined blend. For a full side-by-side, see our dedicated BPC-157 vs TB-500 comparison, and for BPC-157 specifically, our BPC-157 complete guide.
Dosing & The Loading Approach
TB-500 has a characteristic dosing pattern: a higher-frequency loading phase to build up tissue levels, followed by a lower-frequency maintenance phase. The ranges below reflect what's commonly cited in research and protocol literature. They are general informational references, not medical recommendations — and it's worth remembering these patterns come largely from animal data and practitioner observation rather than large human trials.
| Phase | Commonly Cited Approach |
|---|---|
| Loading phase | Around 2–2.5 mg, roughly twice weekly, for about 4–6 weeks |
| Maintenance phase | Around 2–2.5 mg, roughly once weekly |
| Route | Subcutaneous injection (into the fatty layer under the skin) |
| Injection site | Anywhere convenient (abdomen, thigh, upper arm) — systemic distribution |
| Cycle length | Commonly discussed in the range of 4–12 weeks |
The logic of the loading approach is to first build up tissue levels quickly during the intensive phase, then sustain them with less frequent maintenance dosing. Because TB-500 distributes systemically, timing and food don't significantly affect it — consistency matters more than the specific hour. Many people rotate injection sites each dose to keep the skin comfortable.
Reconstitution
TB-500 comes as a lyophilized (freeze-dried) powder that's mixed with bacteriostatic water before use. A common, easy-to-measure preparation:
- Reconstituting a 10 mg vial with 2 ml of bacteriostatic water gives a concentration of 5 mg/ml.
- At that strength, a 2.5 mg dose = 50 units on a standard U-100 insulin syringe (half an ml).
Add the water slowly down the side of the vial and swirl gently rather than shaking. Once mixed, keep it refrigerated and use within about 28 days — and never freeze the reconstituted solution. For a full walkthrough that applies to any peptide, see our how to reconstitute peptides and dosing and injection basics guides. In Costa Rica's climate, proper storage matters especially — see our tropical storage guide.
Safety & Considerations
TB-500 has shown a favorable tolerability profile in preclinical research and in reported use, with side effects generally mild and infrequent at typical doses.
Reported Side Effects
- Injection site reactions (redness, minor irritation) — the most common, as with any injectable
- Temporary fatigue or a "washed out" feeling, sometimes reported early in a protocol
- Mild headache — occasional
- Rarely, mild nausea, more often at higher loading doses
Notably, TB-500 doesn't act on the hormonal (hypothalamic-pituitary) axis, so it doesn't carry the hormonal considerations some compounds do. There's also no strong evidence that it suppresses the body's own Thymosin Beta-4 production — though cycling is still sensible given the limited long-term human data.
Important considerations
Because TB-500 promotes new blood vessel growth (angiogenesis), anyone with a history of cancer should not use it without medical guidance, since increased blood vessel formation is a theoretical concern in that context. It's also sensible to pause use around scheduled surgery and to involve a healthcare professional if you take any medication or have a medical condition. Pregnant or breastfeeding women should avoid it (no safety data). For the full picture, see our side effects and drug interactions guides.
The Sport / WADA Warning
⚠ For competitive athletes
TB-500 has been on the World Anti-Doping Agency (WADA) Prohibited List since 2011, classified among peptide hormones and growth factors. This means competitive athletes subject to anti-doping testing must not use it — it can result in a positive test and sanctions. If you compete in any tested sport, TB-500 is off-limits regardless of the healing benefits. This is a clear, non-negotiable point worth stating plainly.
Common Questions
What is TB-500 used for?
TB-500 is studied primarily for tissue repair and recovery — muscle injuries, tendon and ligament repair, wound and skin healing, and general soft-tissue recovery. Its defining feature is that it's thought to work systemically (throughout the body) rather than just where it's injected, which makes it popular for whole-body recovery. Most of this is grounded in animal research and human data on the parent Thymosin Beta-4 protein.
How is TB-500 different from BPC-157?
They heal through different mechanisms. TB-500 works mainly through actin regulation and cell migration and distributes systemically, so it can be injected anywhere. BPC-157 works more through angiogenesis and nitric-oxide pathways, is especially associated with gut healing, and is often used more locally near an injury. Because they're complementary, they're frequently combined (the "Wolverine Stack"). Neither is a replacement for the other — they're different tools.
Do I need to inject TB-500 near the injury?
No — this is one of its practical advantages. Because TB-500 is thought to distribute throughout the body, an injection anywhere convenient (commonly the abdomen) is expected to produce body-wide effects. This is different from how BPC-157 is often used, where injecting closer to the injury site is sometimes preferred. For TB-500, most people simply inject wherever is easiest and rotate sites.
How long does TB-500 take to work?
Reported timelines vary. Many people with acute injuries describe noticing improvements in comfort and mobility within the first 1–3 weeks of the loading phase, with more significant changes over several weeks. Chronic or severe injuries typically take longer. It's worth remembering that full tendon or ligament healing follows the body's natural remodeling timeline (months); the idea is that TB-500 may support and accelerate that process, not replace it.
Why a loading phase?
The loading phase (higher frequency for the first several weeks) is meant to build up tissue levels relatively quickly, after which a lower-frequency maintenance phase sustains them. This mirrors how the compound is commonly used in practice. Keep in mind these patterns come largely from animal research and practitioner observation rather than large human trials, so they're best approached thoughtfully and ideally with professional input.
Is TB-500 banned in sports?
Yes. TB-500 has been on the WADA Prohibited List since 2011. Any athlete subject to anti-doping testing must avoid it, as it can cause a positive test and sanctions. If you compete in a tested sport, this is a firm no regardless of the recovery benefits. For non-competitive individuals, this particular concern doesn't apply, though all the other considerations in this guide still do.
Can TB-500 be stacked with BPC-157?
Yes — this is the well-known "Wolverine Stack," and it's one of the most popular peptide combinations for recovery. The rationale is that the two work through different healing mechanisms, so together they may cover more of the repair process than either alone. We offer them individually and as a combined blend. As always, if you're new to peptides, it's wise to understand how each affects you before combining.
Is TB-500 legal in Costa Rica?
TB-500 is sold as a research compound in Costa Rica, the same framework used in most countries with active peptide markets. It is sold for laboratory and research purposes. Buying locally avoids the heat exposure that international shipping puts delicate peptides through. See our FAQ page for more.
Questions about TB-500?
Whether you want to understand how TB-500 fits your recovery goals, how it compares to BPC-157, or how the Wolverine Stack works, reach out. We answer every message personally — no pressure, no upsell.
Contact Us on WhatsAppImportant disclaimer: The information in this guide is general educational content only. It is not medical advice, a prescription, or a personalized recommendation. TB-500 is not approved by the FDA, EMA, or Costa Rica's Ministerio de Salud as a finished pharmaceutical drug for human use, and is sold as a research compound intended for laboratory and scientific study. Much of the supporting evidence is preclinical (animal and cell studies) or derived from research on the full-length Thymosin Beta-4 protein rather than the TB-500 fragment; findings should be interpreted with that context. TB-500 is prohibited in competitive sport by WADA. Always consult a qualified healthcare professional before beginning any peptide protocol, especially if you have a history of cancer, a medical condition, take medications, have surgery scheduled, or are pregnant or breastfeeding. Products sold by Peptides Costa Rica are intended for laboratory and research purposes only.
- Annals of the New York Academy of Sciences: Thymosin Beta-4 in tissue repair, cell migration, and wound healing.
- NCBI/PMC: "Thymosin beta-4: a multi-functional regenerative peptide" — mechanism and actin-binding domain.
- Journal of Biological Chemistry: Thymosin Beta-4 and G-actin sequestration.
- Expert Opinion on Biological Therapy: Thymosin Beta-4 clinical development (corneal and dermal wound healing).
- PubChem (NCBI): TB-500 / Thymosin Beta-4 fragment (Ac-LKKTETQ) compound data.
- Circulation Research / cardiac studies: Thymosin Beta-4 in cardiac tissue repair (animal models).
- World Anti-Doping Agency (WADA): Prohibited List — peptide hormones and growth factors (TB-500 prohibited since 2011).
- FDA (2026): Pharmacy Compounding Advisory Committee materials referencing TB-500 review.
- Nature Reviews Drug Discovery: "Therapeutic peptides: current applications and future directions."
